Diabetes registry study for people under 75
Part of Hormones & metabolism clinical trials.
This study collects information about people with diabetes to better understand the condition in everyday life. It may help improve future diabetes care by building a real-world diabetes database.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with diabetes.
- You are under 75 years old.
- You are willing to sign informed consent (agree to join).
- If you are pregnant or breastfeeding, you cannot join.
- You should not be on long-term steroid (glucocorticoid) treatment for another chronic illness.
- You should not have a severe infection or major immune problems (diabetic foot infections are an exception).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a registry (a secure list) of adults with diabetes. It collects information over time to better understand diabetes and support care—your participation is voluntary.
This study sets up a diabetes registry, which means collecting information about people’s diabetes care in a hospital clinic. It may help improve understanding of how diabetes is managed in real life, which can support better future care.
This registry study collects health information from people with diabetes to help researchers better understand and improve diabetes care in Taiwan. It involves no new treatments or procedures.
This trial helps create and manage a diabetes patient database. It may help future research by collecting information from adult patients who agree to participate.
This study records health information to understand how type 2 diabetes and newly diagnosed heart disease affect people over time. It may help doctors learn what to watch for and how to plan care, though it is mainly an observational registry.
This study creates a registry to collect information about patients with diabetes. It helps doctors better understand the disease and its lab results.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.